The effect of propofol on mental health in Saudi Arabia
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20251418Keywords:
Propofol, Anesthesia, Addiction, Down syndromeAbstract
Propofol is a widely used intravenous anesthetic agent with a rapid onset and short duration of action. While extensively utilized for sedation and anesthesia, recent research has raised concerns regarding its impact on mental health, particularly addiction potential, hormonal effects, and neuropsychiatric implications in individuals with underlying neurological conditions. This review aims to examine the neurobiological, hormonal, and psychiatric effects of propofol with a focus on addiction mechanisms, its role in neurodevelopmental and neurodegenerative syndromes, and its modulation of stress- and mood-related hormones, especially within the healthcare landscape of Saudi Arabia. A comprehensive literature review was conducted, drawing from experimental studies, clinical trials, and pharmacological analyses that explored propofol’s interaction with dopamine pathways, hormone regulation, and its implications in syndromes such as Down syndrome, fragile X syndrome (FXS), and Tourette syndrome (TS). Propofol’s interaction with the mesolimbic dopamine system and dopamine transporter (DAT) contributes to its addictive properties. It alters hormonal responses by modulating GABAergic pathways, reducing stress hormone levels such as cortisol and epinephrine. In patients with specific syndromes, propofol demonstrates differential effects on cognition, recovery, and neurological activity, requiring tailored clinical considerations. While propofol remains a cornerstone of modern anesthesia, its psychoactive and addictive potential, especially among healthcare professionals, necessitates stricter regulation and education. Its impact on stress modulation and mental health highlights its dual therapeutic promise and risk, warranting further clinical research and policy development, particularly in Saudi Arabia, where regulatory oversight remains limited.
Metrics
References
Xiong M, Shiwalkar N, Reddy K, Shin P, Bekker A. Neurobiology of propofol addiction and supportive evidence: What is the new development? Brain Sci. 2018;8(2):36. DOI: https://doi.org/10.3390/brainsci8020036
Zhong T, Lin Y, Zhuge R, Lin Y, Huang B, Zeng R. Reviewing the mechanism of propofol addiction. All Life. 2023;16(1):1-9. DOI: https://doi.org/10.1080/26895293.2023.2174708
Zhu X-N, Li J, Gao-Lin Q, Lin W, Chen L, Yi-Ge G, et al. Propofol exerts anti-anhedonia effects via inhibiting the dopamine transporter. Neuron. 2020;111(10):1626-36.
Hwang WJ, Joo MA, Joo J. Effects of anesthetic method on inflammatory response in patients with Parkinson’s disease: A randomized controlled study. BMC Anesthesiol. 2020;20:187. DOI: https://doi.org/10.1186/s12871-020-01112-9
Yoshikawa F, Tamaki Y, Okumura H, Miwa Z, Ishikawa M, Shimoyama K, et al. Risk factors with intravenous sedation for patients with disabilities. Anesthesia Progress. 2013;60(4):153-61. DOI: https://doi.org/10.2344/0003-3006-60.4.153
Lu M, Liu J, Wu X, Zhang Z. Ciprofol: a novel alternative to propofol in clinical intravenous anesthesia?. BioMed Res Int. 2023;2023(1):7443226. DOI: https://doi.org/10.1155/2023/7443226
Song X, Yu B. Anesthetic effects of propofol in the healthy human brain: functional imaging evidence. J Anesth. 2014;29(2):279-88. DOI: https://doi.org/10.1007/s00540-014-1889-4
Kim JL, Bulthuis NE, Cameron HA. The effects of anesthesia on adult hippocampal neurogenesis. Front Neurosci. 2020;14:588356. DOI: https://doi.org/10.3389/fnins.2020.588356
Jacobs T, Mahoney C, Mohammed S, Ziccardi V. Evaluating stromal vascular fraction as a treatment for peripheral nerve regeneration: a scoping review. J Oral Maxillofac Surg. 2024;82(7):771-81. DOI: https://doi.org/10.1016/j.joms.2024.03.024
Paramsothy J, Gutlapalli SD, Ganipineni VD, Mulango I, Okorie IJ, Agbor DB, et al. Propofol in ICU settings: understanding and managing anti arrhythmic, pro-arrhythmic effects, and propofol infusion syndrome.Cureus. 2023;15(6):e40456. DOI: https://doi.org/10.7759/cureus.40456
Lee J, Jung SM, Jeon S. Delayed emergence from propofol anesthesia in a patient with Lesch-Nyhan syndrome: A case report. Medicine. 2020;99(34):e21847. DOI: https://doi.org/10.1097/MD.0000000000021847
Shirk L, Reinert JP. The Role of Propofol in Alcohol Withdrawal Syndrome: A Systematic Review. J Clin Pharmacol. 2025;65(2):170-8. DOI: https://doi.org/10.1002/jcph.6135
Feldman DA, Jones KG, Jacobs R, Vonesh LC, Hoffman N, Lybbert C, et al. A. Short-Term Mood Effects of Repeated Propofol Infusions for Depression. Biological Psychiatry. 2023;93(9):S101. DOI: https://doi.org/10.1016/j.biopsych.2023.02.258
Burnett GW, Taree A, Martin L, Bryson EO. Propofol misuse in medical professions: a scoping review. Canadian J Anesthesia. 2023;70(3):395-405. DOI: https://doi.org/10.1007/s12630-022-02382-2
Ring MT, Pfrimmer DM. Propofol as a drug of diversion: changing disposal practices to reduce risk. Critical Care Nurse. 2021;41(6):45-53. DOI: https://doi.org/10.4037/ccn2021123
Warburton DM. Addiction controversies. 1st ed. CRC Press; 1992.
Koob GF, Kandel DB, Baler RD, Volkow ND. Neurobiology of addiction. In: Tasman A, editors. Tasman’s Psychiatry. Cham: Springer. 2023. DOI: https://doi.org/10.1007/978-3-030-42825-9_29-1
Palabiyik-Yucelik SS, Yoladi FB, Yegenoglu S, Baydar T. The fine line between occupational exposure and addiction to propofol. Istanbul J Pharm. 2023;53(1):95-102. DOI: https://doi.org/10.26650/IstanbulJPharm.2023.1134975
Al Musained MW, AlMahaish AA, Aljohani MD, Al Hashim MN, Alqahtani AK, Al Abdullatif M. Substance abuse among doctors: a review article. Int J Med Dev Ctries. 2021;5(1):387-9. DOI: https://doi.org/10.24911/IJMDC.51-1606843852
Braquehais MD, Bruguera E, Casas M. Addictions in physicians: an overview. In: el-Guebaly N, Carrà G, Galanter M, Baldacchino AM, editors. Textbook of addiction treatment. Cham: Springer. 2021. DOI: https://doi.org/10.1007/978-3-030-36391-8_102
Yang M, Zhang Y. Propofol addiction: the mechanism issues we need to know. APS. 2024;2:6. DOI: https://doi.org/10.1007/s44254-023-00046-y
Uzbay T, Shahzadi A. A comprehensive analysis of propofol abuse and addiction and neuropharmacological aspects: an updated review. Korean J Anesthesiol. 2024;78(2):91-104. DOI: https://doi.org/10.4097/kja.24707
National Center for Biotechnology Information (US). Medical Subject Headings 2017. Bethesda (MD): National Library of Medicine (US). 2017.
Sahinovic MM, Struys MMRF, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet. 2018;57(12):1539-58. DOI: https://doi.org/10.1007/s40262-018-0672-3
Ayele T, Ezeh E, Al-Qawasmi L, Ugonabo OS, Saylor J, Dial L. Diagnosed by reversibility: unmasking propofol-related infusion syndrome in a critically ill elderly male. Cureus. 2022;14(3):e23504. DOI: https://doi.org/10.7759/cureus.23504
National Institute on Drug Abuse. Drugs, brains, and behavior: The science of addiction. NIH Publication No. 14-5605. U. S. Department of Health and Human Services, National Institutes of Health. 2014;25-8.
Cohen JD, Castro-Alamancos MA. Vibrissa-mediated tactile discrimination behavior and neurophysiology in head-fixed mice. Neurosci Biobehav Rev. 2021;127:664-78.
Ackerman TF. Ethical considerations in the randomized evaluation of propofol safety. J Pediatr Pharmacol Ther. 2006;11(1):10-6. DOI: https://doi.org/10.5863/1551-6776-11.1.10
Stocks G. Abuse of propofol by anesthesia providers: the case for reclassification as a controlled substance. J Addict Nurs. 2011;22(1-2):57-62. DOI: https://doi.org/10.3109/10884602.2010.545091
Welliver RC, Welliver MM, McDonough JP. Propofol abuse: a serious occupational hazard. J Korean Med Assoc. 2013;56(9):771-7. DOI: https://doi.org/10.5124/jkma.2013.56.9.771
Alexander S, Kairalla JA, Gupta S, Hibbitts E, Weisman H, Anghelescu D, et al. Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL: A Children's Oncology Group Study. J Clin Oncol. 2024;42(22):2671-9. DOI: https://doi.org/10.1200/JCO.23.01989
Bos MJ, Alzate Sanchez AM, Smeets AYJM, Bancone R, Ackermans L, Absalom AR, et al. Effect of Anesthesia on Microelectrode Recordings during Deep Brain Stimulation Surgery in Tourette Syndrome Patients. Stereotact Funct Neurosurg. 2019;97(4):225-31. DOI: https://doi.org/10.1159/000503691
Qin M, Schmidt KC, Zametkin AJ, Bishu S, Horowitz LM, Burlin TV, et al. Altered cerebral protein synthesis in fragile X syndrome: studies in human subjects and knockout mice. J Cereb Blood Flow Metab. 2013;33(4):499-507. DOI: https://doi.org/10.1038/jcbfm.2012.205
Qin M, Zeidler Z, Moulton K, Krych L, Xia Z, Smith CB. Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome. Behav Brain Res. 2015;291:164-171. DOI: https://doi.org/10.1016/j.bbr.2015.05.003
Niu W, Duan Y, Kang Y, Cao X, Xue Q. Propofol improves learning and memory in post-traumatic stress disorder (PTSD) mice via recovering hippocampus synaptic plasticity. Life Sci. 2022;293:120349. DOI: https://doi.org/10.1016/j.lfs.2022.120349
Xiong J, Wang M, Gao J, Zhou Y, Pang Y, Sun Y. Propofol suppresses hormones levels more obviously than sevoflurane in pediatric patients with craniopharyngioma: a prospective randomized controlled clinical trial. PLoS One. 2023;18(7):e0288863. DOI: https://doi.org/10.1371/journal.pone.0288863
Hempel G, Maier A, Piegeler T, Stehr SN, Kratzsch J, Höhne C. Hormonal blood pressure regulation during general anesthesia using a standardized propofol dosage in children and adolescents seems not to be affected by body weight. J Clin Med. 2020;9(7):2129. DOI: https://doi.org/10.3390/jcm9072129
Orak Y, Tolun Fİ, Bakacak M, Yaylalı A, Kıran H, Öksüz H, et al. Effects of propofol versus sevoflurane on postoperative pain and neuroendocrine stress response in oocyte pickup patients. Pain Res Manag. 2021;2021:5517150. DOI: https://doi.org/10.1155/2021/5517150
Yu L, Zhu X, Peng K, Qin H, Yang K, Cai F, et al. Propofol alleviates anxiety-like behaviors associated with pain by inhibiting the hyperactivity of PVNCRH neurons via GABAA receptor β3 subunits. Adv Sci (Weinh). 2024;11(28):e2309059. DOI: https://doi.org/10.1002/advs.202309059
Ghomeishi A, Mohtadi AR, Behaeen K, Nesioonpour S, Sheida Golbad E, Bakhtiari N. Comparison of the effect of propofol and isoflurane on hemodynamic parameters and stress response hormones during laparoscopic cholecystectomy surgery. J Anaesthesiol Clin Pharmacol. 2022;38(1):137-42. DOI: https://doi.org/10.4103/joacp.JOACP_146_19
Ghomeishi A, Mohtadi AR, Behaeen K, Nesioonpour S, Bakhtiari N, Fahlyani FK. Comparison of the effect of propofol and dexmedetomidine on hemodynamic parameters and stress response hormones during laparoscopic cholecystectomy surgery. Anesthesiol Pain Med. 2021;11(5):e119446. DOI: https://doi.org/10.5812/aapm.119446
Zaloga GP, Youngs E, Teres D. Propofol-containing sedatives increase levels of parathyroid hormone. Intensive Care Med. 2000;26(S3):S405-12. DOI: https://doi.org/10.1007/PL00003784
Channer B, Matt SM, Nickoloff-Bybel EA, Pappa V, Agarwal Y, Wickman J, et al. Dopamine, immunity, and disease. Pharmacol Rev. 2023;75(1):62-158. DOI: https://doi.org/10.1124/pharmrev.122.000618
Gopalakrishnan B, Friedman JH. Dopamine transporter scan (DAT) in Parkinsonism-a short review for non-neurologists. R I Med J. 2023;106(8):29-30.
Zhu Y, Wang K, Ma T, Ji Y, Lou Y, Fu X, et al. Nucleus accumbens D1/D2 circuits control opioid withdrawal symptoms in mice. J Clin Invest. 2023;133(18):e163266. DOI: https://doi.org/10.1172/JCI163266
Zhu XN, Li J, Qiu GL, Wang L, Lu C, Guo YG, et al. Propofol exerts anti-anhedonia effects via inhibiting the dopamine transporter. Neuron. 2023;111(10):1626-36. DOI: https://doi.org/10.1016/j.neuron.2023.02.017
Crampon K, Giorkallos A, Deldossi M, Baud S, Steffenel LA. Machine-learning methods for ligand-protein molecular docking. Drug Discov Today. 2022;27(1):151-64. DOI: https://doi.org/10.1016/j.drudis.2021.09.007
Hameduh T, Haddad Y, Adam V, Heger Z. Homology modeling in the time of collective and artificial intelligence. Comput Struct Biotechnol J. 2020;18:3494-506. DOI: https://doi.org/10.1016/j.csbj.2020.11.007
Kim H, Ku S, Kim H, Suh C, Kim S, Choi Y. Effects of anesthetic agent propofol on postoperative sex hormone levels. Geburtshilfe Frauenheilkd. 2016;76(4):408-12. DOI: https://doi.org/10.1055/s-0041-111571
Qiu X, Yi X, Shi X, The Second People’s Hospital of Gansu Province, Northwest Minda Affiliated Hospital. Analysis of the effect of propofol on ovarian function and the level of sex hormone in peripheral blood of mice. Indian J Pharm Sci. 2021;1044-50. DOI: https://doi.org/10.36468/pharmaceutical-sciences.858
Szuhany KL, Simon NM. Anxiety disorders: a review. JAMA. 2022;328(24):2431-45. DOI: https://doi.org/10.1001/jama.2022.22744
Sears SM, Hewett SJ. Influence of glutamate and GABA transport on brain excitatory/inhibitory balance. Exp Biol Med (Maywood). 2021;246(9):1069-83. DOI: https://doi.org/10.1177/1535370221989263
Downloads
Published
How to Cite
Issue
Section
